Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal lanosterol 14-alpha demethylase is a cytochrome P450 enzyme (CYP51) essential for ergosterol biosynthesis in fungi. It catalyzes the removal of the 14α-methyl group from lanosterol, a key step in ergosterol production. Ergosterol is vital for fungal cell membrane function. The enzyme is a primary target for azole antifungals. Inhibition disrupts membrane integrity, leading to fungal cell death. Resistance development and potential off-target effects are important considerations.
Azoles bind to the heme iron of Lanosterol 14-alpha Demethylase, inhibiting its enzymatic activity and blocking ergosterol synthesis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal Lanosterol 14-alpha Demethylase (CYP51).